Anti-Cd105 Antibody Eliminates Tumor Microenvironment Cells and Enhances Anti-Gd2 Antibody Immunotherapy of Neuroblastoma With Activated Natural Killer Cells

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-18-3358